Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

CLOSING KEYNOTE PANEL DISCUSSION AND RECEPTION: Orthopaedic Innovation Predictions from Surgeon Executives and Entrepreneurs

ROOM 49  | Thursday, June 14 | 1:30 pm - 4:00 pm (Panel from 1:30 pm - 3:00 pm)
Wine and Cheese Reception from 3:00 pm - 4:00 pm

Moderator: John B. Pracyk, M.D., Ph.D, Global Medical Leader, DePuy Synthes Spine, Company of Johnson & Johnson 

Panelists:
Peter Althausen, M.D., Chairman and Treasurer, Orthopaedic Implant Company, and Trauma Surgeon, Reno Orthopaedic Clinic
Mark I. Froimson, M.D., Past President, American Association of Hip and Knee Surgeons
Patrick Sweeney, M.D., Spine Surgeon, Founder, Center for Minimally Invasive Surgery, Flow-Fx and ConnectSx 


 

Description

Where is the greatest room for innovation in orthopaedics? OMTEC’s Closing Panel brings together surgeon executives and entrepreneurs with diverse market backgrounds—joint reconstruction, spine and trauma—to provide perspective on ways that orthopaedic manufacturers can develop new products and services to help hospitals and surgery centers respond to the pressures they face. By answering questions about value vs. volume, declining reimbursement, opportunities outside of direct patient care and areas for innovation, surgeons will provide device manufacturers—and contract manufacturers—perspective on how to prioritize product development, both iterative and transformational. A wine and cheese reception will take place immediately following the panel discussion to provide an opportunity to ask these surgeons your pressing questions and network with your industry colleagues. 

 

Attendee Takeaways

  1. Ways OEMs can innovate in an environment of declining margins
  2. Perspective on how hospital purchasing changes will impact orthopaedic innovation
  3. Surgeon perspective on product needs in joint reconstruction, spine and trauma

 

 

 


Bios

Pracyk 200x200As an experienced neurological surgeon and national thought leader in the design, development and management of collaborative care delivery, John Pracyk, M.D., Ph.D. is a passionate proponent of value-based care and outcomes-focused clinical practices. Possessing a sophisticated vision of healthcare’s future, he is an inclusive influencer of uncompromising integrity who inspires peak performance, internal/external partnership-building and is recognized as a proactive innovator who motivates high-performing teams to out-pace healthcare benchmarks, exceed patient care expectations and fuel organizational transformation. At DePuy Synthes, Dr. Pracyk provides deep clinical insights to accelerate meaningful innovation and drive value and safety for spine patients worldwide. He serves as a strategic medical partner with colleagues across Research and Development, Franchise Marketing, Clinical, Regulatory Affairs, Medical Safety and Business Development at Johnson & Johnson Medical Devices. Dr. Pracyk obtained his M.D. and Ph.D. degrees from Duke University, and completed his neurosurgical training at The George Washington University. He recently completed a Healthcare M.B.A. at The Haslam College of Business at the University of Tennessee.


Althausen 200x200Peter Althausen, M.D. received his medical degree from Tufts University School of Medicine in Boston, Massachusetts. While in medical school, he also received an MBA in healthcare administration from the same institution. Special areas of interest include pelvis and acetabular fractures, periarticular fractures and complex polytraumatic injuries. Dr. Althausen serves as a Clinical Assistant Professor at the University of Nevada School of Medicine, where he teaches and mentors medical and college students. Dr. Althausen is the Chairman and Treasurer of the Orthopaedic Implant Company, a value-based device company that was started in 2010 and has over 20 FDA cleared products.


Froimson 200x200Mark I. Froimson, M.D. is Past President of the American Association of Hip and Knee Surgeons (AAHKS) and a thought leader in value-based healthcare. He previously served as Executive Vice President and Chief Clinical Officer for Trinity Health and President and CEO of Euclid Hospital, a Cleveland Clinic Hospital. He was staff surgeon in the Department of Orthopaedic Surgery at the Cleveland Clinic for over 16 years, during which time he held leadership positions including President of the Professional Staff, Vice Chair of the Orthopaedic and Rheumatologic Institute, and member of the Board of Governors and Board of Trustees. After receiving a degree in Philosophy from Princeton University, and his medical degree from Tulane University School of Medicine, Dr. Froimson completed his general surgical and orthopaedic training at the University of California, Los Angeles and Columbia-Presbyterian Medical Center. He completed his Fellowship in Adult Reconstructive Surgery at the University Hospitals of Cleveland. Dr. Froimson is board certified in orthopaedic surgery. Once in practice, he received his Master’s in Business Administration from the Weatherhead School of Business at Case Western Reserve University.


Sweeney 200x200After starting his professional life as a CPA, Patrick Sweeney, M.D. received his medical training at the Royal College of Surgeons in Ireland and Northwestern University Medical School in Chicago, and was a fellow at the University of Louisville’s Leatherman Spine fellowship. In addition to being a practicing surgeon, Dr. Sweeney founded the Center for Minimally Invasive Surgery in Mokena, Illinois in 2002, and holds more than 30 patents in the United States, Germany, France, and England, many of which form the basis for Flow-FX’s revolutionary technologies. He also founded ConnextSx, which provides a platform of SaaS solutions to decrease waste and improve visibility in the surgical value chain.